SEC Form 4 · accession 0001179110-15-006144
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William S Marth
Officer — President and CEO · Director
Period of report
Apr 7, 2015
Accepted (ET)
Apr 8, 2015 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 7, 2015 | M | 10,000 | $2.59 | A | 424,847 | D | |
| Common StockF1 | Apr 7, 2015 | M | 12,367 | $5.99 | A | 437,214 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2 | $2.59 | Apr 7, 2015 | M | 10,000 | A | — | Jun 13, 2022 | Common Stock | 10,000 | 0 | D |
| Option to Purchase Common StockF3 | $5.99 | Apr 7, 2015 | M | 12,367 | A | — | Jan 31, 2023 | Common Stock | 12,367 | 0 | D |
Explanation of responses
- F1The transactions reported on this Form 4 represent solely the exercise of certain stock options previously reported as acquired by the Reporting Person.
- F2Option grant was fully exercisable on June 13, 2013.
- F3Option grant was fully exercisable on January 31, 2014.